•Enhancing intracellular ROS scavenging by chondroitin sulfate-modified ceria nanozymes for the treatment of inflammatory bowel disease and enteropathic arthritis
•Long-term outcomes of top-down therapy versus a conventional step-up strategy in adults newly diagnosed with Crohn's disease: 5-year follow-up of the PROFILE trial
•Respiratory Adverse Effects of IBD Treatments: Mechanisms, Manifestations, and Management Strategies
•Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)
•Colombian registry of inflammatory bowel disease in pediatrics
